Stegmann said, 'We make vaccines based on virosomes, very small particles. They can be suitable for fighting the coronavirus, because they generate a good immune response.'
Sylvain Fleury Chief Scientific Officer at Mymetics Corporation Post-doctoral fellowship Company Name NIH Dates Employed Jan 1993 – Dec 1996 Employment Duration4 yrs Studying the MHC classe II and CD4 structure-function in the context of antigen presentation. Fellowship with Dr. Ronald N. Germain from the NIAID (Bethesda, Maryland, USA).
Market Data 
Markets 
AI
